“This work will provide the mechanistic basis for and identify the metabolic vulnerabilities of difficult-to-treat DLBCLs and contribute to designing new therapeutic approaches for currently incurable patients,” Dr. Mlynarczyk says.
Researcher Spotlight
View All >Coraline Mlynarczyk, PhD